ASCO 2021 Kidney Cancer - Results from #40

Viewing 41-48 of 48 articles

ASCO 2021: Integration of Multimodality Treatment in Advanced Kidney Cancer: The Roles of Surgery and Radiation Therapy

ASCO 2021: Nivolumab plus Cabozantinib vs Sunitinib for Advanced Renal Cell Carcinoma: Outcomes by Baseline Disease Characteristics in the Phase 3 CheckMate 9ER Trial

ASCO 2021: Outcomes of Patients Who Progressed While Receiving Avelumab + Axitinib and Received Subsequent Treatment in JAVELIN Renal 101

ASCO 2021: Novel Therapeutics on the Horizon in Advanced Kidney Cancer

ASCO 2021: Practical Systemic Therapy Considerations after Frontline Immunotherapy Combination

ASCO 2021: Association of C-Reactive Protein With Efficacy of Avelumab + Axitinib in Advanced Renal Cell Carcinoma: Long-Term Follow-Up Results From JAVELIN Renal 101

ASCO 2021: Integrating Peripheral Biomarker Analyses From JAVELIN Renal 101: Avelumab + Axitinib vs Sunitinib in Advanced Renal Cell Carcinoma

ASCO 2021: Novel Strategies to Improve Outcomes in Advanced Renal Cell Carcinoma

1
2
3